RAPP
Rapport Therapeutics, Inc.
NasdaqGMUSDEQUITY
Healthcare
DELAYED
Neutral
-20/100
Last price
31.00
▼ 1.19 (3.70%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
33.00
Prev close
32.19
Day high
34.00
Day low
30.01
Volume
235.64K
Market cap
$1.49B
P/E (TTM)
—
52W range
23.75 – 52.93
Day trading desk
Gap from prior close
+2.52%
Prior close 32.19
VWAP
31.21
-0.67% from price
Relative volume
0.51×
Quiet session
Session range
13.30%
30.01 – 34.00
Position in range
25%
Near session low
ATR (14D)
2.68
8.63% of price
Prior day high
32.71
PDH
Prior day low
31.53
PDL
Bid / ask spread
—
Quote not published
Session volume
194.14K
Avg 379.80K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-5.66%
-7.6%
1M
-31.94%
-33.1%
3M
-25.82%
-30.3%
6M
-6.99%
-25.2%
YTD
+2.67%
-11.6%
1Y
+9.15%
-7.3%
3Y
—
-82.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on RAPP open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
1.87M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 30, 26 | GAULT CHERYL Chief Operating Officer |
SELL | 10.00K | $331.86K | Direct |
| Sep 23, 26 | CEESAY ABRAHAM N Chief Executive Officer |
SELL | 2.21K | $86.27K | Direct |
| Sep 8, 26 | CEESAY ABRAHAM N Chief Executive Officer |
SELL | 8.21K | $374.50K | Direct |
| Aug 25, 26 | CEESAY ABRAHAM N Chief Executive Officer |
SELL | 18.92K | $937.96K | Direct |
| Aug 25, 26 | YELESWARAM KRISHNASWAMY Officer |
SELL | 50.16K | $2.53M | Direct |
| Aug 19, 26 | YELESWARAM KRISHNASWAMY Officer |
SELL | 404 | $20.16K | Direct |
| Aug 11, 26 | CEESAY ABRAHAM N Chief Executive Officer |
SELL | 51.50K | $2.43M | Direct |
| Jul 27, 26 | CEESAY ABRAHAM N Chief Executive Officer |
SELL | 2.21K | $93.06K | Direct |
| Jul 14, 26 | CEESAY ABRAHAM N Chief Executive Officer |
SELL | 8.21K | $328.44K | Direct |
| Jun 30, 26 | GAULT CHERYL Chief Operating Officer |
SELL | 10.00K | $415.80K | Direct |
| Jun 29, 26 | CEESAY ABRAHAM N Chief Executive Officer |
SELL | 8.22K | $327.40K | Direct |
| May 26, 26 | THIRD ROCK VENTURES V, L.P. Beneficial Owner of more than 10% of a Class of Security |
SELL | 18.57K | $743.75K | Indirect |
| May 11, 26 | THIRD ROCK VENTURES V, L.P. Beneficial Owner of more than 10% of a Class of Security |
SELL | 133.62K | $5.38M | Indirect |
| May 8, 26 | THIRD ROCK VENTURES V, L.P. Beneficial Owner of more than 10% of a Class of Security |
SELL | 276.51K | $11.09M | Indirect |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BREDT DAVID |
Officer | 393.07K | Conversion of Exercise of derivative security |
CEESAY ABRAHAM N |
Chief Executive Officer | 559.23K | Sale |
GAULT CHERYL |
Chief Operating Officer | 139.91K | Sale |
HUBER REID M. |
Director | 20.40K | Purchase |
IGNELZI TROY A |
Chief Financial Officer | 10.00K | Purchase |
PAUL STEVEN M |
Director | — | Purchase |
THIRD ROCK VENTURES V, L.P. |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
YELESWARAM KRISHNASWAMY |
Officer | 195.86K | Sale |
YOUNG WENDY B. |
Director | 9.50K | Purchase |
Fundamentals
Market cap$1.49B
Enterprise value$1.07B
Revenue (TTM)$20.00M
Gross profit$-21.88M
EBITDA$-152.56M
Net income$-137.16M
EPS (TTM)$-2.93
Free cash flow$-56.02M
Total cash$436.08M
Total debt$10.11M
Book value / share$8.82
Shares outstanding47.98M
Float32.39M
Short % of float7.42%
Dividend yield0.00%
Beta (5Y)1.22
Valuation & profitability ratios
Trailing P/E—
Forward P/E-5.96
PEG ratio—
Price / sales—
Price / book3.53
EV / revenue53.43
EV / EBITDA-7.00
Gross margin-109.39%
Operating margin-767.58%
Profit margin0.00%
Return on equity-39.96%
Return on assets-25.78%
Debt / equity2.39
Current ratio15.72
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | — |
| Operating revenue | $0 | $0 | $0 | — |
| Research & development | $94.79M | $60.94M | $28.00M | +55.6% |
| Selling, general & admin | $30.31M | $22.12M | $8.18M | +37.0% |
| Total operating expense | $125.10M | $83.06M | $36.18M | +50.6% |
| Operating income | -$125.10M | -$83.06M | -$36.18M | -50.6% |
| Net interest income | $13.62M | $12.14M | $2.53M | +12.2% |
| Pre-tax income | -$111.48M | -$78.31M | -$34.78M | -42.4% |
| Tax provision | — | $0 | $10.00K | — |
| Net income | -$111.48M | -$78.31M | -$34.79M | -42.4% |
| Net income to common | -$111.48M | -$78.31M | -$34.79M | -42.4% |
| Basic EPS | -2.86 | -3.78 | -23.10 | +24.3% |
| Diluted EPS | -2.86 | -3.78 | -23.10 | +24.3% |
| EBIT | -$125.10M | -$83.06M | -$36.18M | -50.6% |
| EBITDA | -$124.08M | -$82.22M | -$36.07M | -50.9% |
| Basic shares | 38.93M | 20.74M | 1.51M | +87.7% |
| Diluted shares | 38.93M | 20.74M | 1.51M | +87.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $52.65M | $56.80M | $70.17M | $31.16M | -7.3% |
| Cash & short-term investments | $490.54M | $305.28M | $147.48M | $31.16M | +60.7% |
| Total current assets | $498.56M | $309.80M | $150.87M | $31.27M | +60.9% |
| Property, plant & equipment | $12.88M | $4.97M | $4.00M | $335.00K | +159.2% |
| Total assets | $512.43M | $314.93M | $155.42M | $31.60M | +62.7% |
| Total current liabilities | $19.05M | $8.77M | $8.80M | $1.66M | +117.3% |
| Total debt | $11.48M | $1.48M | $2.15M | $0 | +678.0% |
| Total liabilities | $27.78M | $9.51M | $181.06M | $41.66M | +192.2% |
| Retained earnings | -$235.23M | -$123.75M | -$45.44M | -$10.65M | -90.1% |
| Shareholder equity | $484.65M | $305.43M | -$25.63M | -$10.06M | +58.7% |
| Working capital | $479.51M | $301.04M | $142.07M | $29.61M | +59.3% |
| Net tangible assets | $484.65M | $305.43M | -$25.63M | -$10.06M | +58.7% |
| Shares issued | 47.77M | 36.58M | 35.38M | 35.38M | +30.6% |
| Line item | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|
| Net income | -$111.48M | -$78.31M | -$34.79M | -42.4% |
| Depreciation & amortisation | $1.02M | $839.00K | $112.00K | +21.2% |
| Stock-based compensation | $18.86M | $10.23M | $3.52M | +84.2% |
| Change in working capital | $3.50M | -$2.42M | $2.65M | +245.0% |
| Operating cash flow | -$87.47M | -$64.83M | -$27.18M | -34.9% |
| Capital expenditure | -$616.00K | -$2.40M | -$1.64M | +74.4% |
| Investing cash flow | -$187.47M | -$170.14M | -$78.86M | -10.2% |
| Share buybacks | -$1.00K | $0 | -$4.00K | — |
| Financing cash flow | $270.79M | $221.63M | $145.14M | +22.2% |
| Free cash flow | -$88.09M | -$67.23M | -$28.82M | -31.0% |
| End cash position | $52.75M | $56.91M | $70.25M | -7.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $0 | $20.00M | $0 | $0 | $0 | -100.0% |
| Operating revenue | $0 | $20.00M | $0 | $0 | $0 | -100.0% |
| Research & development | $51.41M | $32.72M | $30.26M | $22.28M | $22.68M | +57.2% |
| Selling, general & admin | $9.39M | $11.50M | $8.25M | $7.71M | $6.82M | -18.3% |
| Total operating expense | $60.81M | $44.22M | $38.51M | $29.99M | $29.50M | +37.5% |
| Operating income | -$60.81M | -$24.21M | -$38.51M | -$29.99M | -$29.50M | -151.1% |
| Net interest income | $4.19M | $4.36M | $4.75M | $3.06M | $2.76M | -3.8% |
| Pre-tax income | -$56.62M | -$19.86M | -$33.76M | -$26.93M | -$26.73M | -185.1% |
| Net income | -$56.62M | -$19.86M | -$33.76M | -$26.93M | -$26.73M | -185.1% |
| Net income to common | -$56.62M | -$19.86M | -$33.76M | -$26.93M | -$26.73M | -185.1% |
| Basic EPS | -1.19 | -0.42 | -0.72 | -0.71 | -0.75 | -183.3% |
| Diluted EPS | -1.19 | -0.42 | -0.72 | -0.71 | -0.75 | -183.3% |
| EBIT | -$60.81M | -$24.21M | -$38.51M | -$29.99M | -$29.50M | -151.1% |
| EBITDA | -$60.59M | -$23.99M | -$38.24M | -$29.73M | -$29.24M | -152.6% |
| Basic shares | 47.47M | 47.24M | 46.98M | 37.93M | 35.44M | +0.5% |
| Diluted shares | 47.47M | 47.24M | 46.98M | 37.93M | 35.44M | +0.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $63.61M | $78.06M | $52.65M | $251.36M | $55.07M | -18.5% |
| Cash & short-term investments | $436.08M | $476.78M | $490.54M | $513.03M | $260.45M | -8.5% |
| Accounts receivable | $293.00K | $58.00K | — | — | — | +405.2% |
| Total current assets | $446.86M | $484.69M | $498.56M | $520.66M | $270.24M | -7.8% |
| Property, plant & equipment | $11.07M | $11.85M | $12.88M | $13.60M | $14.22M | -6.6% |
| Total assets | $458.98M | $497.60M | $512.43M | $535.32M | $285.50M | -7.8% |
| Total current liabilities | $28.42M | $17.90M | $19.05M | $14.32M | $11.88M | +58.8% |
| Total debt | $10.11M | $10.80M | $11.48M | $11.87M | $11.86M | -6.5% |
| Total liabilities | $36.06M | $26.09M | $27.78M | $23.71M | $21.98M | +38.2% |
| Retained earnings | -$311.70M | -$255.09M | -$235.23M | -$201.47M | -$174.54M | -22.2% |
| Shareholder equity | $422.93M | $471.51M | $484.65M | $511.62M | $263.51M | -10.3% |
| Working capital | $418.43M | $466.80M | $479.51M | $506.34M | $258.36M | -10.4% |
| Net tangible assets | $422.93M | $471.51M | $484.65M | $511.62M | $263.51M | -10.3% |
| Shares issued | 47.96M | 47.81M | 47.77M | 47.65M | 36.50M | +0.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$56.62M | -$19.86M | -$33.76M | -$26.93M | -$26.73M | -185.1% |
| Depreciation & amortisation | $212.00K | $227.00K | $265.00K | $256.00K | $252.00K | -6.6% |
| Stock-based compensation | $7.20M | $6.96M | $5.69M | $4.74M | $4.39M | +3.4% |
| Change in working capital | $6.81M | -$765.00K | $3.61M | $3.70M | -$3.37M | +989.8% |
| Operating cash flow | -$41.45M | -$13.06M | -$24.70M | -$17.46M | -$25.07M | -217.4% |
| Capital expenditure | -$78.00K | -$86.00K | -$169.00K | -$134.00K | -$22.00K | +9.3% |
| Investing cash flow | $25.60M | $37.94M | -$174.32M | -$56.78M | $22.60M | -32.5% |
| Share buybacks | $0 | -$5.00K | $0 | $0 | $0 | +100.0% |
| Financing cash flow | $1.41M | $531.00K | $311.00K | $270.53M | -$63.00K | +165.7% |
| Free cash flow | -$41.53M | -$13.15M | -$24.87M | -$17.60M | -$25.09M | -215.9% |
| End cash position | $63.72M | $78.16M | $52.75M | $251.46M | $55.17M | -18.5% |
Options analytics
Put / call volume
0.26
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
22.50
-27.8% from spot
ATM implied vol
6.3%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
157
Contracts, this expiry
Put volume
41
Contracts, this expiry
Heaviest call OI
32.50
0 contracts
Heaviest put OI
22.50
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.99 | -1.19 | -20.4% |
| Mar 2026 | -0.71 | -0.42 | +40.7% |
| Dec 2025 | -0.67 | -0.72 | -6.8% |
| Sep 2025 | -0.73 | -0.71 | +3.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -1.23 | 10 | $0 | 0.0% |
| Next quarter | -1.23 | 10 | $0 | 0.0% |
| Current year | -4.09 | 10 | $20.00M | 0.0% |
| Next year | -5.09 | 10 | $0 | -100.0% |
Analyst targets & ownership
Mean target$63.04
High target$80.00
Low target$50.00
Implied upside103.37%
Analyst count13
ConsensusSTRONG BUY
Strong buy / Buy1 / 13
Hold0
Sell / Strong sell0 / 0
Held by insiders3.90%
Held by institutions108.93%
Institutions holding226
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
33.03
-6.14% from price
SMA 20
37.64
-17.25% from price
SMA 50
43.11
-27.75% from price
SMA 100
40.97
-24.34% from price
SMA 200
35.81
-13.00% from price
EMA 12
34.55
-10.27% from price
EMA 26
38.16
-18.77% from price
EMA 50
40.33
-23.13% from price
RSI (14)
22.6
Oversold
MACD (12,26,9)
-3.62
Hist -0.52
ATR (14)
2.68
8.59% of price
Realised vol 30D
64.1%
Annualised
Bollinger upper
47.18
20, 2σ
Bollinger lower
28.11
20, 2σ
50 / 200 cross
Golden
43.11 vs 35.81
Trend bias
Below 200
-13.00%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.24
More volatile than market
Correlation to SPY
0.28
Largely independent
Realised vol 30D
64.1%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-40.7%
Peak to trough
Max drawdown 5Y
-75.5%
Peak to trough
ATR 14
2.68
8.59% of price
Beta (reported)
1.22
5Y monthly, from filing
Short interest
Shares short
2.25M
Prior 2.23M
Change vs prior
+1.0%
Shorts adding
% of float
7.42%
Normal
% of shares out
4.69%
Against total outstanding
Days to cover
8.0
Crowded exit
Float
32.39M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 6, 26 | Guggenheim | INITIATED | — | Buy |
| Sep 16, 26 | BTIG | MAINTAINED | Buy | Buy |
| Aug 19, 26 | BTIG | MAINTAINED | Buy | Buy |
| Aug 12, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Aug 5, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jul 16, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jun 24, 26 | Leerink Partners | INITIATED | — | Outperform |
| May 21, 26 | BTIG | MAINTAINED | Buy | Buy |
| May 8, 26 | BTIG | MAINTAINED | Buy | Buy |
| Apr 22, 26 | BTIG | MAINTAINED | Buy | Buy |
| Mar 11, 26 | BTIG | MAINTAINED | Buy | Buy |
| Mar 11, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-05
Corporate Changes & Voting Matters
8-K · 2026-06-10
Periodic Financial Reports
10-Q · 2026-05-07
Proxy Statements
DEF 14A · 2026-04-23
Corporate Changes & Voting Matters
8-K · 2026-04-21
Periodic Financial Reports
10-K · 2026-03-10
Corporate Changes & Voting Matters
8-K · 2026-01-07
Periodic Financial Reports
10-Q · 2025-11-06
Headlines
Guggenheim Initiates Rapport Therapeutics at Buy With $65 Price Target
MT Newswires · 19h ago
The Biggest Losers In Biotech — And It Had Nothing To Do With 'Compelling,' 'Best-In-Disease' Data
Investor's Business Daily · 13d ago
The Zacks Analyst Blog Highlights Kodiak Sciences, Celldex Therapeutics, Rapport Therapeutics and Vaxcyte
Zacks · 14d ago
4 Biotech Stocks With Key Clinical Readouts Expected This Fall
Zacks · 15d ago
Rapport Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire · 35d ago
Rapport Therapeutics to Host Virtual KOL Event on the Unmet Need in Bipolar Mania and the RAP-219 Clinical Program
GlobeNewswire · 44d ago
Rapport Therapeutics Reports Second Quarter 2026 Financials and Provides Business Update
GlobeNewswire · 63d ago
William Blair Initiates Rapport Therapeutics at Outperform
MT Newswires · 71d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.